please note that due to acquisition of Celgene Corporation (CELG) by Bristol-Myers Squibb Company (BMY) announced earlier on November 20th, Teletrade stops offering CFD on CELG.
Any remaining positions in CELG shall be closed by the Company based on the the last available price on November 26, 2019, between 18:00 and 21:00 server time, after which the symbol wil be closed (all related trading reports will still be available).
Please refer to Bristol-Myers Squibb official release for more details: https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-completes-acquisition-celgene-creating-le
A new symbol "BMY" for Bristol-Myers Squibb Company will be available for trading starting December 2, 2019.
© 2000-2023. All rights reserved.
This site is managed by Teletrade D.J. Limited 20599 IBC 2012 (First Floor, First St. Vincent Bank Ltd Building, James Street, Kingstown, St. Vincent and the Grenadines).
The information on this website is for informational purposes only and does not constitute any investment advice.
Making transactions on financial markets with marginal financial instruments opens up wide possibilities and allows investors who are willing to take risks to earn high profits, carrying a potentially high risk of losses at the same time. Therefore you should responsibly approach the issue of choosing the appropriate investment strategy, taking the available resources into account, before starting trading.
Use of the information: full or partial use of materials from this website must always be referenced to TeleTrade as the source of information. Use of the materials on the Internet must be accompanied by a hyperlink to teletrade.org. Automatic import of materials and information from this website is prohibited.
Please contact our PR department if you have any questions or need assistance at firstname.lastname@example.org.